The complexity of cancer necessitates a multifaceted approach to research and treatment. Collaborative agreements allow for sharing of unique resources and expertise, which can lead to breakthroughs that might not be possible through isolated efforts. Such collaborations can lead to the discovery of new biomarkers, innovative treatment modalities, and improved clinical trial designs.
